Subsequent NGS of 450 early-onset colorectal cancer patients from Ohio utilizing a 25-gene panel identified only one CHEK2 pathogenic mutation; however, the authors reported another 18 CHEK2 variants as VUS (including six p.I157T) [239]. Here, CHEK2 is linked to colorectal cancer.